B. Braun Medical Inc. is recalling 1,380 units of Heparin Sodium (25,000 USP units per 250mL) in 5% Dextrose injection. The recall was issued because the medication was found to be subpotent, which means it has lower levels of anti-factor IIa potency than required. No incidents or injuries have been reported to date regarding this issue.
If a patient receives a low-potency dose of Heparin, which is a blood thinner, it may not effectively prevent or treat blood clots. This could lead to serious medical complications from untreated clotting conditions.
API from Spain
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.